U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07327294) titled 'A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor' on Dec. 12, 2025.
Brief Summary: This study is an open-label, dose-escalation, multicenter Phase I/II study conducted in patients with advanced solid tumors. The target population for this study consists of patients with advanced solid tumors who have failed or are intolerant to standard treatments. The study is divided into two parts: the dose-escalation phase and the dose-expansion phase.
Study Start Date: Jan. 31
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: XNW34017
Drug Name: XNW34017 Tablets Dosa...